Mead-Johnson-Nanomaterials-Enfamil-2017 (status: Annual Meeting Cancelled)

RESOLVED: Shareholders request the Board publish, at reasonable cost and excluding proprietary information, a report on the potential health hazards of nanomaterials, particularly of nano-HA; identifying the types of the company’s products or packaging that currently contain nanoparticles; and stating any actions management is taking to reduce or eliminate potential health and environmental risks of nanoparticles, such as eliminating the use of nanoparticles until or unless they are proven safe through long-term testing.

Filing Documents